SPOTLIGHT: Wockhardt lining up $800M for Alpharma bid?

The Economic Times is reporting that India's Wockhardt is lining up $800 million to buy US generic drug company Alpharma. Alpharma announced last week that it is considering alternative strategies. Another potential suitor could be India's Ranbaxy, another major generic drug company. Story